Clinical outcomes and management of JAK inhibitor-associated acne in patients with moderate-to-severe atopic dermatitis undergoing upadacitinib: A multicenter retrospective study

• DOI: 10.1016/j.jaad.2024.01.004
• Publication Date: 2024-01-09T01:19:41Z
• Authors: Gianluca Avallone; Luca Mastorino; Gianluca Tavoletti; Nicole Macagno; Francesca Barei; Donatella Schena; Mariateresa Rossi; Elisabetta Magnat...; Flaminia Antonelli; Graziella Babino; Riccardo Viola; Luigi Gargiulo; Claudio Conforti; Luca Rapparini; Enzo Errichetti; Cataldo Patruno; Pasqualina Ruggiero; Gabriele Roccuzzo; Carlo A. Maronese; Giampiero Girolomoni; Massimo Gola; Andrea Chiricozzi; Anna Balato; Francesca Ambrogio; Alessandra Narcisi; Iris Zalaudek; Carlotta Gurioli; Maddalena Napolitano; Angelo V. Marzano; Caterina Foti; Antonio Costanzo; Bianca M. Piraccini; Silvia M. Ferrucci; Michela Ortoncelli; Pietro Quaglino; Simone Ribero
• Keywords: acne; acneiform eruption; atopic dermatitis; JAK inhibitors; side effects; upadacitinib; JAK inhibitors; acne; acneiform eruption; atopic dermatitis; side effects; upadacitinib; JAK inhibitors; acneiform eruption; atopic dermatitis; upadacitinib; Dermatitis, Atopic; side effects; Treatment Outcome; Acne Vulgaris; Humans; Janus Kinase Inhibitors; acne; Heterocyclic Compounds, 3-Ring; Retrospective Studies

Clinical outcomes and management of JAK inhibitor-associated acne in patients with moderate-to-severe atopic dermatitis undergoing upadacitinib: A multicenter retrospective study